Seminar report | How to make resistance-proof antibiotics (LSHTM, 16 November 2017 – Dr Luiz Pedro Carvalho)

One of the big challenges for tackling antimicrobial resistance is the lack of new antibiotics in the development pipeline. When investigating or selecting new compounds to take forward into pre-clinical and clinical development, it will be important to select drugs that are likely to have a long shelf life – i.e. ones that will delay […]

The Third Man: How are we entwined with antimicrobials today?

Please note this blog contains spoilers   By Vinesh Patel   In the world of film – as in the world of antimicrobial resistance (AMR) – perhaps not all is as it first seems. If you had told me, “Let’s see a black and white thriller from 1949” a month ago, I may not have […]

‘Superbugs and the Role of Diagnostics – Longitude Prize 3rd Anniversary’

By Daria Tserkovnaya Tuesday 14 November, during World Antibiotic Awareness Week, marked the third anniversary of the Longitude Prize and has attracted 250 participants from over 40 countries worldwide. Taking place at Nesta, London and hosted by TV GP, Dr Zoe Williams, the event was attended by a number of Longitude Prize competitors with promising developments […]

Celebrating World Antibiotic Awareness Week with a new Student Liaison Officer team

Happy World Antibiotic Awareness Week everyone! Is this an event to celebrate? On the one hand, maybe not. Antimicrobial resistance is one of the biggest challenges facing public health professionals right now and will likely continue to be so for many years to come. Our ability to treat common infectious diseases is under threat from […]

Routine genomic surveillance of MRSA can detect unsuspected outbreaks

The first complete picture of MRSA spread within and between hospitals, GPs surgeries and communities in the east of England, has been revealed through genomic surveillance. Conducted by the London School of Hygiene & Tropical Medicine and Wellcome Trust Sanger Institute, and published in Science Translational Medicine, the research has important implications for infection control. […]

One Health and Antimicrobial Resistance

8 of November 2017 5pm – 7pm Royal Veterinary College  Great Hall, Camden, Royal College Street, NW1 0TU   To celebrate the International One Health day, we are delighted to invite you to this free, public evening event that will take place at the Royal Veterinary College in Camden, London. Resistance to antimicrobials is currently one […]

Are you passionate about AMR?

Antimicrobial Resistance Centre Student Liaison Officers Centre Background: The Antimicrobial Resistance (AMR) Centre aims to help improve and support antimicrobial resistance research at LSHTM and worldwide. Its objectives are to:   Promote and facilitate high quality research into AMR that builds on and exploits disciplinary strengths across LSHTM. Facilitate AMR related funding responses and collaboration […]

LSHTM takes central role in national PhD training programme to tackle antimicrobial resistance

In response to the urgent and global threat of antimicrobial resistance (AMR), the Medical Research Foundation (MRF), the charitable foundation of the Medical Research Council, has invested £2.85M in delivering the UK’s first nationwide PhD training programme to focus on this major health challenge.   Projects led by Professor Alison Grant and Dr Clare Chandler […]

External events you might be interested in

The DRIVE-AB final conference: Revitalizing the antibiotic pipeline, stimulating innovation while driving sustainable use and global access The final DRIVE-AB conference is a high-level event aimed at policy- and decision-makers from across the globe, as well as regulatory and public health experts and economists from institutions including the World Health Organization, the World Bank, the […]

Latest news: External | 14 August 2017

New proposal addresses challenging market dynamics for antibiotics A strategy that combines a market entry reward with population-based payments from insurers could provide the kind of “pull” incentive that US pharmaceutical companies need to bring new high-priority antibiotics to market, according to a new paper by a team of experts from Duke University. [More information] […]